Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Academic ophthalmologists are pushing to retire the term "dry eye disease," but community eye doctors say not so fast. A report from a Colombian tertiary clinic identified a "pain-predominant phenotype" in 6.9% of DED patients — those with high symptoms but minimal objective signs — sparking debate over whether this niche finding should reshape how the entire field diagnoses and treats dry eye.
A recent report published in Ophthalmology from a tertiary dry eye clinic in Colombia has reignited a long-simmering debate in the field: should "dry eye disease" be renamed — or even reconceptualized entirely? The study identified a "pain-predominant phenotype" among patients who reported significant discomfort and photophobia but showed minimal objective signs of dryness. Academic commentators have used this finding to question whether inflammation and evaporation are truly the right pillars of DED diagnosis and treatment, with some floating alternatives like "ocular surface discomfort syndrome."
Community ophthalmologist Dr. Darrell White pushes back, arguing that this phenotype represents a small, highly selected slice of patients seen at specialized referral centers — not the broader population of DED sufferers that community doctors treat daily. He cautions that overhauling the diagnostic framework based on a tertiary-care minority could undermine treatment algorithms that already work well for the vast majority of patients.
By the Numbers:
Why it matters: The tension between academic "splitters" and community "lumpers" in dry eye care has real consequences for patients. Restructuring DED around rare phenotypes could complicate care for the millions who benefit from current, proven treatment pathways — and widen the gap between academic research and everyday clinical practice.